PRQR - ProQR Therapeutics BV - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PRQR is currently covered by 6 analysts with an average price target of $7.88. This is a potential upside of $5.88 (294%) from yesterday's end of day stock price of $2.

ProQR Therapeutics BV's activity chart (see below) currently has 11 price targets and 31 ratings on display. The stock rating distribution of PRQR is 85% BUY and 15% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.21% with an average time for these price targets to be met of 129.22 days.

Highest price target for PRQR is $6, Lowest price target is $1.8, average price target is $7.88.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 08-Nov-2023. First documented stock forecast 26-Sep-2017.

Currently out of the existing stock ratings of PRQR, 17 are a BUY (85%), 3 are a HOLD (15%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2

$-0.13 (-6.10%)

2

5 months 12 days ago

4/4 (100%)

$0.65 (48.15%)

159

Buy

4

$1.87 (87.79%)

5

5 months 12 days ago

1/4 (25%)

$2.65 (196.30%)

132

Buy

1.8

$-0.33 (-15.49%)

2.25

7 months 2 days ago

3/4 (75%)

$0.26 (16.88%)

29

Buy

5

$2.87 (134.74%)

5

8 months 13 days ago

2/7 (28.57%)

$3.58 (252.11%)

174

Buy

4.5

$2.37 (111.27%)

5

11 months 3 days ago

0/2 (0%)

$2.75 (157.14%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRQR (ProQR Therapeutics BV) average time for price targets to be met?

On average it took 129.22 days on average for the stock forecasts to be realized with a an average price target met ratio 40.21

Which analyst has the current highest performing score on PRQR (ProQR Therapeutics BV) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on PRQR (ProQR Therapeutics BV) with a proven track record?

DAE GON HA

Which analyst has the most public recommendations on PRQR (ProQR Therapeutics BV)?

Keay Nakae works at CHARDAN CAPITAL and has 7 price targets and 5 ratings on PRQR

Which analyst is the currently most bullish on PRQR (ProQR Therapeutics BV)?

Liisa Bayko with highest potential upside - $16.87

Which analyst is the currently most reserved on PRQR (ProQR Therapeutics BV)?

Yigal Nochomovitz with lowest potential downside - -$0.33

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?